Join the Virtual 6 Challenge and complete 6 miles in 6 days , whether you run, jog, hike, bike, paddle or swim, in any location you choose. March 24-29, 2026 ...
As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...
Johnson & Johnson (NYSE: JNJ) said its experimental immune therapy nipocalimab cleared a major clinical hurdle in systemic ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...
Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...
Lupus is often marked by flares, which is when symptoms are usually more obvious.
Johnson & Johnson (NYSE: JNJ) today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a ...
Positive full results from the Phase III TULIP-SC trial showed the subcutaneous (SC) administration of Saphnelo (anifrolumab) demonstrated a ...
Abstract: Lupus is an autoimmune disorder with the majority of the cases being Systemic Lupus Erythematosus (SLE). Diagnosis of SLE is time consuming due to the broad range of tests, with no one test ...
Actress the late Choi Jin-sil's daughter Choi Jun-hee recalled the painful experience she had in the past due to lupus. On the 21st, Choi Jun-hee uploaded a photo of her leg taken during her battle ...